HIS
VYNE icon

Harvest Investment Services’s VYNE Therapeutics VYNE Stock Holding History

Harvest Investment Services’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.61K Hold
11,059
– – ﹤0.01% 346
2025
Q4 		$6.42K Hold
11,059
– – ﹤0.01% 327
2025
Q3 		$3.71K Sell
11,059
-40,267
-78% -$26.3K ﹤0.01% 319
2025
Q2 		$84.7K Buy
+51,326
New +$66.7K 0.02% 315

Other funds holding VYNE

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Harvest Investment Services's VYNE Position: Q1 2026 in Review

Harvest Investment Services held its VYNE Therapeutics (VYNE) position steady in Q1 2026 at 11,059 shares worth $6.61K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Harvest Investment Services first reported a position in VYNE in Q2 2025 and has held it in 4 quarters since. The position peaked at $84.7K in Q2 2025. 45 funds tracked by Wall St. Rank hold VYNE as of Q1 2026.

  • Harvest Investment Services held 11,059 shares of VYNE Therapeutics worth $6.61K as of Q1 2026.
  • Harvest Investment Services left its VYNE Therapeutics share count unchanged in Q1 2026.
  • VYNE Therapeutics made up ﹤0.01% of Harvest Investment Services's portfolio in Q1 2026, its #346 holding.
  • Harvest Investment Services first reported a position in VYNE Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Harvest Investment Services's VYNE Therapeutics position peaked at $84.7K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2026.

Based on Harvest Investment Services's 13F filing for Q1 2026, filed 15 May 2026.